Erin MacKinney

  • General Surgery
  • Endocrine Surgery


Education

  • MD, Medical College of Wisconsin, 2015
  • Resident, Southern Illinois University School of Medicine, General Surgery, 2020
  • Fellowship, NorthShore University HealthSystem, Endocrine Surgery, 2021

Clinical Specialties

Dr. MacKinney specializes in Endocrine and General Surgery.

Recent Publications

  • Treatment Differences for Adrenocortical Carcinoma by Race and Insurance Status.
    Holoubek SA, MacKinney EC, Khokar AM, Kuchta KM, Winchester DJ, Prinz RA, Moo-Young TA
    J Surg Res 2022 Dec; 280: 169-178
    [PubMed ID: 35987166]

  • Impact of Endocrinologist and Surgeon Density on Well-Differentiated Thyroid Cancer Survival.
    McDow AD, Lanzotti N, Zahnd WE, MacKinney EC, Angelos P, Mellinger JD, Ganai S
    Am Surg 2022 Nov; 88(11): 2626-2632
    [PubMed ID: 35591793]

  • Treatment differences at high volume centers and low volume centers in non-metastatic and metastatic adrenocortical carcinoma.
    MacKinney EC, Holoubek SA, Khokar AM, Kuchta KM, Moo-Young TA, Prinz RA, Winchester DJ
    Am J Surg 2022 Mar; 223(3): 582-586
    [PubMed ID: 35151433]

  • Overall survival is improved with total thyroidectomy and radiation for male patients and patients older than 55 with T2N0M0 Stage 1 classic papillary thyroid cancer.
    MacKinney EC, Kuchta KM, Winchester DJ, Khokar AM, Holoubek SA, Moo-Young TA, Prinz RA
    Surgery 2022 Jan; 171(1): 197-202
    [PubMed ID: 34666913]

  • Radioactive iodine does not improve overall survival for patients with aggressive variants of papillary thyroid carcinoma less than 2 cm.
    Holoubek SA, MacKinney EC, Khokar AM, Kuchta KM, Winchester DJ, Prinz RA, Moo-Young TA
    Surgery 2022 Jan; 171(1): 203-211
    [PubMed ID: 34384604]

All Publications on PubMed